Health hot news

UroToday.com - Our multi-institutional study on robotic partial nephrectomy for renal hilar tumors is the first to focus solely on renal hilar tumors and represents one of the largest series in the world. Laparoscopic partial nephrectomy requires advanced skills in laparoscopy to achieve precise tumor resection and renal reconstruction while minimizing warm ischemia times and minimizing the risk of complications, such as urinary fistula and postoperative bleeding.

In a development that researchers say is likely to quell concerns about the value of costly computed tomography (CT) scans to diagnose coronary artery blockages, an international team led by researchers at Johns Hopkins reports solid evidence that the newer, more powerful 64-CT scans can easily and correctly identify people with major blood vessel disease and is nearly as accurate as invasive coronary angiography. Reporting in the New England Journal of Medicine online Nov.

VIDA Diagnostics Inc. announced that its primary product, Pulmonary Workstation 2.0 (PW2) has obtained FDA 510(k) clearance for sale. PW2 is the first commercial release of lung image analysis software from VIDA and comprises a comprehensive approach to quantitative, repeatable lung measurements including the industry’s first so-approved automatic lobe density and airway system measurement functions.

German biotech company Partec is expanding its global leadership in specialized HIV monitoring and AIDS patient follow-up diagnostics for developing and emerging countries. In the year 2008, 2.5 million patient tests have been performed with the portable, robust and highly affordable “CyFlow” system, supporting already more than 1 million people living with HIV/AIDS.

Suffering from end-stage renal disease (ESRD), a growing number of patients at the Centre hospitalier de l’Université de Montréal (CHUM), have become the beneficiaries of a North American breakthrough: high efficacy hemodiafiltration (HDF). An extracorporeal blood purification technique, HDF is indicated for ESRD patients.

Hitachi Europe Ltd, Display Products Group (DPG) has announced the introduction of a new 19inch 1.7MegaPixel WSXGA+ TFT display module. The new TX48D21VM0CAA display implements the latest evolution of Hitachi’s In-Plane-Switching technology, IPS-Pro, which provides a stable colour image from any viewing angle, excellent colour saturation and a very high contrast ratio.

Sorin Group, (MIL:SRN), a global company and a leader in the treatment of cardiovascular diseases, announced today the commercial market release and first implant of its new-generation PARADYM™ CRT 8750 cardiac resynchronization therapy defibrillator (CRT-D). Together with the new SITUS™ BW 28D left ventricle pacing lead and lead delivery system, PARADYM CRT forms a complete new CRT system for heart failure (HF) patients.

Mentice proudly announces the launch of two new products for endovascular simulation training - the Mentice VIST 7.7 enhanced training modules for Carotid and Coronary interventions. New features such as vital signs, complications, medication management and measurement functionality add to the clinical realism and enhance the educational value of simulation training.

Judith Sheft, associate vice president for technology development at NJIT, has been awarded funds from the New Jersey Commission on Science and Technology to assist faculty researchers with the most promising patentable inventions with funding grants of up to $50,000. The money, known as Gap grants, is designed to help bridge the chasm between an interesting idea and a commercial product. Sixteen grants have been made since 2006 to NJIT faculty researchers.

Oxoid, a world leading microbiology brand, offers a range of valuable diagnostic tools for the detection of respiratory disease caused by influenza virus Types A and B. Rapid diagnosis of Influenza A or B virus infections plays an important role in patient management, influencing the use of antiviral therapy and enabling effective management and control of outbreaks. Influenza virus infections peak in the winter months1 and remain a major health concern.